Nurix Therapeutics Ownership | Who Owns Nurix Therapeutics?
Nurix Therapeutics Ownership Summary
Nurix Therapeutics is owned by 10.80% institutional investors, 1.09% insiders, and 88.11% retail investors. Blackrock is the largest institutional shareholder, holding 12.42% of NRIX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.16% of its assets in Nurix Therapeutics shares.
NRIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nurix Therapeutics | 10.80% | 1.09% | 88.11% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.82M | 12.42% | $142.33M |
| Fmr | 8.89M | 10.56% | $82.12M |
| Blackrock funding, inc. /de | 6.76M | 8.04% | $62.49M |
| Deep track capital, lp | 6.06M | 7.20% | $55.97M |
| Vanguard group | 4.49M | 5.33% | $41.48M |
| Baker bros. advisors lp | 3.88M | 4.61% | $35.87M |
| Commodore capital lp | 3.78M | 4.49% | $34.93M |
| Redmile group | 3.68M | 4.37% | $33.99M |
| Vestal point capital, lp | 3.48M | 4.13% | $32.11M |
| Point72 asset management | 2.87M | 3.41% | $26.53M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 3.68M | 3.31% | $33.99M |
| Commodore capital lp | 3.78M | 1.71% | $34.93M |
| Deep track capital, lp | 6.06M | 1.56% | $55.97M |
| Kynam capital management, lp | 2.17M | 1.49% | $20.04M |
| Vestal point capital, lp | 3.48M | 1.45% | $32.11M |
| Soleus capital management | 2.42M | 1.13% | $22.39M |
| Patient square capital lp | 437.24K | 1.08% | $4.04M |
| Affinity asset advisors | 967.62K | 0.78% | $8.94M |
| Boxer capital management | 175.00K | 0.52% | $1.62M |
| Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group | 85.00K | 0.46% | $785.40K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 6.82M | 0.00% | 2.24M |
| Vestal point capital, lp | 3.48M | 1.45% | 1.48M |
| Deutsche bank ag\ | 1.44M | 0.00% | 1.07M |
| Kynam capital management, lp | 2.17M | 1.49% | 995.00K |
| Algert global | 563.84K | 0.09% | 449.34K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 1.10M | 0.00% | -1.93M |
| Fmr | 8.89M | 0.00% | -1.55M |
| Ra capital management | - | - | -1.33M |
| T. rowe price investment management | 1.20M | 0.01% | -1.28M |
| Ubs group | 362.55K | 0.00% | -1.23M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 318.80K | 0.00% | 318.80K | $6.01M |
| Jane street group | 258.65K | 0.00% | 258.65K | $2.39B |
| Marshall wace, llp | 246.79K | 0.00% | 246.79K | $2.28M |
| Connor, clark & lunn investment management | 61.52K | 0.00% | 61.52K | $568.40M |
| Lighthouse investment partners | 50.00K | 0.01% | 50.00K | $462.00K |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -1.00 |
| True wealth design | -4.00 |
| Ifp advisors | -6.00 |
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Federated hermes | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 46 | -72.12% | 9,091,319 | -89.71% | 10 | 0.10% | 18 | -80.43% | 17 | -59.52% |
| Jun 30, 2025 | 164 | -4.09% | 88,304,128 | 5.07% | 105 | 1.04% | 91 | -3.19% | 42 | -17.65% |
| Mar 31, 2025 | 171 | -3.93% | 84,588,676 | 4.29% | 101 | 0.69% | 93 | -11.43% | 51 | 10.87% |
| Dec 31, 2024 | 177 | 1.72% | 81,111,271 | 20.04% | 120 | 1.40% | 103 | 9.57% | 47 | -16.07% |
| Sep 30, 2024 | 174 | -1.14% | 67,568,477 | 3.95% | 92 | 0.66% | 94 | -16.81% | 56 | 24.44% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.42M | 3.16% | -53.57K |
| Vanguard US Total Market Shares ETF | 2.13M | 2.79% | 196.50K |
| iShares Russell 2000 ETF | 1.82M | 2.38% | - |
| Fidelity Select Health Care | 1.69M | 2.21% | 90.00K |
| ARK Genomic Revolution | 1.54M | 2.01% | -28.29K |
| ARK Genomic Revolution ETF | 1.53M | 2.01% | -5.47K |
| Amova ARK Pstv Chg Innovt P JPY Acc | 1.42M | 1.86% | 322.21K |
| US Small-Cap Growth II Equity Comp | 1.35M | 1.76% | 14.21K |
| Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.10M | 1.44% | 273.18K |
| T. Rowe Price Integrated US SmCapGrEq | 985.71K | 1.39% | 492.85K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 24, 2025 | Ring Christine | Chief Legal Officer | Sell | $641.70K |
| Nov 03, 2025 | van Houte Hans | Chief Financial Officer | Sell | $78.93K |
| Oct 30, 2025 | van Houte Hans | Chief Financial Officer | Sell | $40.05K |
| Oct 30, 2025 | Ring Christine | Chief Legal Officer | Sell | $46.63K |
| Oct 30, 2025 | Hansen Gwenn | Chief Scientific Officer | Sell | $52.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | 10 |
NRIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools